R. Scott McClelland, MD, MPH

Professor of Medicine (AID), Epidemiology, and Global Health

 

Dr. Scott McClelland, MPH, MD, is a Professor of Medicine in the Division of Allergy and Infectious Diseases at the University of Washington. He holds joint appointments in the Departments of Epidemiology and Global Health, and is a member of the University of Nairobi STD/HIV/sexual and reproductive health (SRH) Research Group. Dr. McClelland is a co-Principal Investigator for the University of Washington Vaccine and Treatment Evaluation Unit (VTEU), which includes sites in Seattle, Kenya, South Africa, and Peru. The VTEU conducts non-HIV clinical trials including those directed at pandemic response, respiratory viruses, neglected tropical diseases, malaria, enteric infections, and STIs. Dr. McClelland’s primary research interest focuses on the intersection between infectious diseases and women’s reproductive health. Methodologically, his work spans clinical trials, mHealth interventions, observational epidemiological studies, and implementation research.

Publications

  1. Heller, KB, Mohamed, JS, Cherne, SL, Onono, M, Bukusi, EA, Njoroge, BW et al.. High agreement of Seegene AnyplexTM HPV 28 and AllplexTM HPV 28 for High-Risk Vaccine-Type HPV Detection in the KEN SHE Study. J Virol Methods. 2026; :115395. doi: 10.1016/j.jviromet.2026.115395. PubMed PMID:41962590 .
  2. Sabo, MC, Shah, JA, Lund, JM, McClelland, RS. Understanding the cervicovaginal immune response to Lactobacillus crispatus CTV-05. Lancet Microbe. 2027; :101377. doi: 10.1016/j.lanmic.2026.101377. PubMed PMID:41794050 .
  3. Oyaro, B, Wanje, G, Richardson, BA, Temmerman, M, McClelland, RS, Eastment, M et al.. A mixed-methods assessment of individual client-level and clinic-level factors associated with uptake of cervical cancer screening (CCS) services in family planning (FP) clinics receiving an intervention to support these services in Mombasa County, Kenya. Implement Sci Commun. 2026;7 (1):21. doi: 10.1186/s43058-025-00852-4. PubMed PMID:41508153 PubMed Central PMC12882629.
  4. Graham, SM, Otieno, FO, Kimani, J, Barrientos, A, Soge, OO, Sharma, M et al.. World Health Organization-Recommended Periodic Presumptive Treatment Versus Doxycycline Post-Exposure Prophylaxis for Sexually Transmitted Infection Control Among Men Who Have Sex With Men in Kenya: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2026;15 :e81113. doi: 10.2196/81113. PubMed PMID:41494183 PubMed Central PMC12820545.
  5. Krause, A, Zane, GK, Rivas-Nieto, AC, Mulugeta, A, Hossain, MR, McClelland, RS et al.. Assessing the relationship between menstrual products and reproductive and urogenital tract infections (RUTIs): A systematic review evaluating the evidence and recommendations for future research. PLoS One. 2025;20 (12):e0332006. doi: 10.1371/journal.pone.0332006. PubMed PMID:41428672 PubMed Central PMC12721514.
Search PubMed